Literature DB >> 9122178

Molecular characterization of human and mouse fatty acid amide hydrolases.

D K Giang1, B F Cravatt.   

Abstract

Recently, we reported the isolation, cloning, and expression of a rat enzyme, fatty acid amide hydrolase (FAAH), that degrades bioactive fatty acid amides like oleamide and anandamide to their corresponding acids, thereby serving to terminate the signaling functions of these molecules. Here, we report the molecular characterization of both a mouse and a human FAAH and compare these enzymes to the rat FAAH. The enzymes are well conserved in primary structure, with the mouse and rat FAAHs sharing 91% amino acid identity and the human FAAH sharing 82% and 84% identity with the rat FAAH and mouse FAAH, respectively. In addition, the expressed human and rat FAAHs behave biochemically as membrane proteins of comparable molecular size and show similar, but distinguishable, enzymological properties. The identification of highly homologous FAAH proteins in rat, mouse, and human supports a general role for the fatty acid amides in mammalian biology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122178      PMCID: PMC20071          DOI: 10.1073/pnas.94.6.2238

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Authors:  B F Cravatt; D K Giang; S P Mayfield; D L Boger; R A Lerner; N B Gilula
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

2.  Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.

Authors:  S Feng; J K Chen; H Yu; J A Simon; S L Schreiber
Journal:  Science       Date:  1994-11-18       Impact factor: 47.728

3.  Involvement of a membrane-bound form of glutamate dehydrogenase in the association of lysosomes to microtubules.

Authors:  F Rajas; V Gire; B Rousset
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

4.  Cerebrodiene: a brain lipid isolated from sleep-deprived cats.

Authors:  R A Lerner; G Siuzdak; O Prospero-Garcia; S J Henriksen; D L Boger; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides.

Authors:  J Barg; E Fride; L Hanus; R Levy; N Matus-Leibovitch; E Heldman; M Bayewitch; R Mechoulam; Z Vogel
Journal:  Eur J Pharmacol       Date:  1995-12-12       Impact factor: 4.432

6.  Purification, cloning, and primary structure of an enantiomer-selective amidase from Brevibacterium sp. strain R312: structural evidence for genetic coupling with nitrile hydratase.

Authors:  J F Mayaux; E Cerebelaud; F Soubrier; D Faucher; D Pétré
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

7.  Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors.

Authors:  J P Huidobro-Toro; R A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  Isolation of fatty acid amide as an angiogenic principle from bovine mesentery.

Authors:  K Wakamatsu; T Masaki; F Itoh; K Kondo; K Sudo
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

9.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Authors:  W A Devane; L Hanus; A Breuer; R G Pertwee; L A Stevenson; G Griffin; D Gibson; A Mandelbaum; A Etinger; R Mechoulam
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

10.  Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.

Authors:  D G Deutsch; S A Chin
Journal:  Biochem Pharmacol       Date:  1993-09-01       Impact factor: 5.858

View more
  107 in total

1.  Activity-based protein profiling: the serine hydrolases.

Authors:  Y Liu; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.

Authors:  Amy K Dickason-Chesterfield; Stephanie R Kidd; Steven A Moore; John M Schaus; Bin Liu; George G Nomikos; Christian C Felder
Journal:  Cell Mol Neurobiol       Date:  2006-05-31       Impact factor: 5.046

Review 3.  Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide.

Authors:  Matthew J McFarland; Ekaterina A Terebova; Eric L Barker
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

4.  Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.

Authors:  Chitra Sridar; Natasha T Snider; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2011-02-02       Impact factor: 3.922

5.  Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.

Authors:  Haibin Wang; Huirong Xie; Xiaofei Sun; Philip J Kingsley; Lawrence J Marnett; Benjamin F Cravatt; Sudhansu K Dey
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-11-28       Impact factor: 3.072

Review 6.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

7.  Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.

Authors:  Jessica K DeMartino; Joie Garfunkle; Dustin G Hochstatter; Benjamin F Cravatt; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2008-06-28       Impact factor: 2.823

8.  A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist.

Authors:  Natasha T Snider; James A Nast; Laura A Tesmer; Paul F Hollenberg
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

9.  Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

Authors:  Katerina Otrubova; Monica Brown; Michael S McCormick; Gye W Han; Scott T O'Neal; Benjamin F Cravatt; Raymond C Stevens; Aron H Lichtman; Dale L Boger
Journal:  J Am Chem Soc       Date:  2013-04-12       Impact factor: 15.419

10.  Functional disassociation of the central and peripheral fatty acid amide signaling systems.

Authors:  Benjamin F Cravatt; Alan Saghatelian; Edward G Hawkins; Angela B Clement; Michael H Bracey; Aron H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.